Gene Therapy Progress and Prospects: Electroporation and other physical methods
10.1038/sj.gt.3302337
Crossref journal-article
Springer Science and Business Media LLC
Gene Therapy (297)
Bibliography

Wells, D. J. (2004). Gene Therapy Progress and Prospects: Electroporation and other physical methods. Gene Therapy, 11(18), 1363–1369.

Authors 1
  1. D J Wells (first)
References 84 Referenced 292
  1. Comerota AJ et al. Naked plasmid DNA encoding fibroblast growth factor type 1 for the treatment of end-stage unreconstructible lower extremity ischemia: preliminary results of a phase I trial. J Vasc Surg 2002; 35: 930–936. (10.1067/mva.2002.123677) / J Vasc Surg by AJ Comerota (2002)
  2. Losordo DW et al. Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia. Circulation 2002; 105: 2012–2018. (10.1161/01.CIR.0000015982.70785.B7) / Circulation by DW Losordo (2002)
  3. Gothelf A, Mir LM, Gehl J . Electrochemotherapy: results of cancer treatment using enhanced delivery of bleomycin by electroporation. Cancer Treat Rev 2003; 29: 371–387. (10.1016/S0305-7372(03)00073-2) / Cancer Treat Rev by A Gothelf (2003)
  4. Bigey P, Bureau MF, Scherman D . In vivo plasmid DNA electrotransfer. Curr Opin Biotechnol 2002; 13: 443–447. (10.1016/S0958-1669(02)00377-4) / Curr Opin Biotechnol by P Bigey (2002)
  5. Gehl J . Electroporation: theory and methods, perspectives for drug delivery, gene therapy and research. Acta Physiol Scand 2003; 177: 437–447. (10.1046/j.1365-201X.2003.01093.x) / Acta Physiol Scand by J Gehl (2003)
  6. McMahon JM, Wells DJ . Electroporation for gene transfer to skeletal muscles: current status. BioDrugs 2004; 18: 155–165. (10.2165/00063030-200418030-00002) / BioDrugs by JM McMahon (2004)
  7. Bloquel C, Fabre E, Bureau MF, Scherman D . Plasmid DNA electrotransfer for intracellular and secreted proteins expression: new methodological developments and applications. J Gene Med 2004; 6 (Suppl 1): S11–S23. (10.1002/jgm.508) / J Gene Med by C Bloquel (2004)
  8. Golzio M, Teissie J, Rols MP . Direct visualization at the single-cell level of electrically mediated gene delivery. Proc Natl Acad Sci USA 2002; 99: 1292–1297. (10.1073/pnas.022646499) / Proc Natl Acad Sci USA by M Golzio (2002)
  9. Budker V et al. Hypothesis: naked plasmid DNA is taken up by cells in vivo by a receptor-mediated process. J Gene Med 2000; 2: 76–88. (10.1002/(SICI)1521-2254(200003/04)2:2<76::AID-JGM97>3.0.CO;2-4) / J Gene Med by V Budker (2000)
  10. Bureau MF et al. Intramuscular plasmid DNA electrotransfer: biodistribution and degradation. Biochim Biophys Acta 2004; 1676: 138–148. (10.1016/j.bbaexp.2003.11.005) / Biochim Biophys Acta by MF Bureau (2004)
  11. Zhang L, Nolan E, Kreitschitz S, Rabussay DP . Enhanced delivery of naked DNA to the skin by non-invasive in vivo electroporation. Biochim Biophys Acta 2002; 1572: 1–9. (10.1016/S0304-4165(02)00270-2) / Biochim Biophys Acta by L Zhang (2002)
  12. Bureau MF et al. Importance of association between permeabilization and electrophoretic forces for intramuscular DNA electrotransfer. Biochim Biophys Acta 2000; 1474: 353–359. (10.1016/S0304-4165(00)00028-3) / Biochim Biophys Acta by MF Bureau (2000)
  13. McMahon JM et al. Optimisation of electrotransfer of plasmid into skeletal muscle by pretreatment with hyaluronidase – increased expression with reduced muscle damage. Gene Therapy 2001; 8: 1264–1270. (10.1038/sj.gt.3301522) / Gene Therapy by JM McMahon (2001)
  14. Durieux AC, Bonnefoy R, Busso T, Freyssenet D . In vivo gene electrotransfer into skeletal muscle: effects of plasmid DNA on the occurrence and extent of muscle damage. J Gene Med 2004; 6: 809–816. (10.1002/jgm.534) / J Gene Med by AC Durieux (2004)
  15. Dean DA et al. Electroporation as a method for high-level nonviral gene transfer to the lung. Gene Therapy 2003; 10: 1608–1615. (10.1038/sj.gt.3302053) / Gene Therapy by DA Dean (2003)
  16. Ohashi S et al. Successful genetic transduction in vivo into synovium by means of electroporation. Biochem Biophys Res Commun 2002; 293: 1530–1535. (10.1016/S0006-291X(02)00386-8) / Biochem Biophys Res Commun by S Ohashi (2002)
  17. Lin CR et al. Electroporation for direct spinal gene transfer in rats. Neurosci Lett 2002; 317: 1–4. (10.1016/S0304-3940(01)02354-0) / Neurosci Lett by CR Lin (2002)
  18. Dezawa M et al. Gene transfer into retinal ganglion cells by in vivo electroporation: a new approach. Micron 2002; 33: 1–6. (10.1016/S0968-4328(01)00002-6) / Micron by M Dezawa (2002)
  19. Matsuda T, Cepko CL . Electroporation and RNA interference in the rodent retina in vivo and in vitro. Proc Natl Acad Sci USA 2004; 101: 16–22. (10.1073/pnas.2235688100) / Proc Natl Acad Sci USA by T Matsuda (2004)
  20. Wells KE et al. Enhanced in vivo delivery of antisense oligonucleotides to restore dystrophin expression in adult mdx mouse muscle. FEBS Lett 2003; 552: 145–149. (10.1016/S0014-5793(03)00904-9) / FEBS Lett by KE Wells (2003)
  21. Heller LC, Coppola D . Electrically mediated delivery of vector plasmid DNA elicits an antitumor effect. Gene Therapy 2002; 9: 1321–1325. (10.1038/sj.gt.3301802) / Gene Therapy by LC Heller (2002)
  22. Tamura T et al. Combination of IL-12 and IL-18 of electro-gene therapy synergistically inhibits tumor growth. Anticancer Res 2003; 23: 1173–1179. / Anticancer Res by T Tamura (2003)
  23. Kishida T et al. Electrochemo-gene therapy of cancer: intratumoral delivery of interleukin-12 gene and bleomycin synergistically induced therapeutic immunity and suppressed subcutaneous and metastatic melanomas in mice. Mol Ther 2003; 8: 738–745. (10.1016/j.ymthe.2003.08.002) / Mol Ther by T Kishida (2003)
  24. Liu F, Huang L . Electric gene transfer to the liver following systemic administration of plasmid DNA. Gene Therapy 2002; 9: 1116–1119. (10.1038/sj.gt.3301733) / Gene Therapy by F Liu (2002)
  25. Tollefsen S et al. Improved cellular and humoral immune responses against Mycobacterium tuberculosis antigens after intramuscular DNA immunisation combined with muscle electroporation. Vaccine 2002; 20: 3370–3378. (10.1016/S0264-410X(02)00289-X) / Vaccine by S Tollefsen (2002)
  26. Zhang L et al. Accelerated immune response to DNA vaccines. DNA Cell Biol 2003; 22: 815–822. (10.1089/104454903322625028) / DNA Cell Biol by L Zhang (2003)
  27. Scheerlinck JP et al. In vivo electroporation improves immune responses to DNA vaccination in sheep. Vaccine 2004; 22: 1820–1825. (10.1016/j.vaccine.2003.09.053) / Vaccine by JP Scheerlinck (2004)
  28. Tjelle TE et al. Monoclonal antibodies produced by muscle after plasmid injection and electroporation. Mol Ther 2004; 9: 328–336. (10.1016/j.ymthe.2003.12.007) / Mol Ther by TE Tjelle (2004)
  29. Fukuchi-Shimogori T, Grove EA . Neocortex patterning by the secreted signaling molecule FGF8. Science 2001; 294: 1071–1074. (10.1126/science.1064252) / Science by T Fukuchi-Shimogori (2001)
  30. Saito T, Nakatsuji N . Efficient gene transfer into the embryonic mouse brain using in vivo electroporation. Dev Biol 2001; 240: 237–246. (10.1006/dbio.2001.0439) / Dev Biol by T Saito (2001)
  31. Tabata H, Nakajima K . Efficient in utero gene transfer system to the developing mouse brain using electroporation: visualization of neuronal migration in the developing cortex. Neuroscience 2001; 103: 865–872. (10.1016/S0306-4522(01)00016-1) / Neuroscience by H Tabata (2001)
  32. Wei F et al. Calmodulin regulates synaptic plasticity in the anterior cingulate cortex and behavioral responses: a microelectroporation study in adult rodents. J Neurosci 2003; 23: 8402–8409. (10.1523/JNEUROSCI.23-23-08402.2003) / J Neurosci by F Wei (2003)
  33. Wang Z et al. Detection of integration of plasmid DNA into host genomic DNA following intramuscular injection and electroporation. Gene Therapy 2004; 11: 711–721. (10.1038/sj.gt.3302213) / Gene Therapy by Z Wang (2004)
  34. Zhang G et al. Hydroporation as the mechanism of hydrodynamic delivery. Gene Therapy 2004; 11: 675–682. (10.1038/sj.gt.3302210) / Gene Therapy by G Zhang (2004)
  35. Andrianaivo F et al. Hydrodynamics-based transfection of the liver: entrance into hepatocytes of DNA that causes expression takes place very early after injection. J Gene Med 2004, online in advance of print. (10.1002/jgm.574)
  36. Kobayashi N et al. Hepatic delivery of particulates in the submicron range by a hydrodynamics-based procedure: implications for particulate gene delivery systems. J Gene Med 2004; 6: 455–463. (10.1002/jgm.531) / J Gene Med by N Kobayashi (2004)
  37. Kobayashi N, Nishikawa M, Hirata K, Takakura Y . Hydrodynamics-based procedure involves transient hyperpermeability in the hepatic cellular membrane: implication of a nonspecific process in efficient intracellular gene delivery. J Gene Med 2004; 6: 584–592. (10.1002/jgm.541) / J Gene Med by N Kobayashi (2004)
  38. Ehrhardt A et al. Optimization of cis-acting elements for gene expression from nonviral vectors in vivo. Hum Gene Ther 2003; 14: 215–225. (10.1089/10430340360535779) / Hum Gene Ther by A Ehrhardt (2003)
  39. Alino SF, Crespo A, Dasi F . Long-term therapeutic levels of human alpha-1 antitrypsin in plasma after hydrodynamic injection of nonviral DNA. Gene Therapy 2003; 10: 1672–1679. (10.1038/sj.gt.3302065) / Gene Therapy by SF Alino (2003)
  40. Lewis DL et al. Efficient delivery of siRNA for inhibition of gene expression in postnatal mice. Nat Genet 2002; 32: 107–108. (10.1038/ng944) / Nat Genet by DL Lewis (2002)
  41. McCaffrey AP et al. RNA interference in adult mice. Nature 2002; 418: 38–39. (10.1038/418038a) / Nature by AP McCaffrey (2002)
  42. Maruyama H et al. High-level expression of naked DNA delivered to rat liver via tail vein injection. J Gene Med 2002; 4: 333–341. (10.1002/jgm.281) / J Gene Med by H Maruyama (2002)
  43. Eastman SJ et al. Development of catheter-based procedures for transducing the isolated rabbit liver with plasmid DNA. Hum Gene Ther 2002; 13: 2065–2077. (10.1089/10430340260395910) / Hum Gene Ther by SJ Eastman (2002)
  44. Maruyama H et al. Kidney-targeted naked DNA transfer by retrograde renal vein injection in rats. Hum Gene Ther 2002; 13: 455–468. (10.1089/10430340252792585) / Hum Gene Ther by H Maruyama (2002)
  45. Liu F, Lei J, Vollmer R, Huang L . Mechanism of liver gene transfer by mechanical massage. Mol Ther 2004; 9: 452–457. (10.1016/j.ymthe.2003.12.003) / Mol Ther by F Liu (2004)
  46. Liu F, Nishikawa M, Clemens PR, Huang L . Transfer of full-length Dmd to the diaphragm muscle of Dmd(mdx/mdx) mice through systemic administration of plasmid DNA. Mol Ther 2001; 4: 45–51. (10.1006/mthe.2001.0419) / Mol Ther by F Liu (2001)
  47. Zhang G et al. Efficient expression of naked DNA delivered intraarterially to limb muscles of nonhuman primates. Hum Gene Ther 2001; 12: 427–438. (10.1089/10430340150504046) / Hum Gene Ther by G Zhang (2001)
  48. Eggermont AM, de Wilt JH, ten Hagen TL . Current uses of isolated limb perfusion in the clinic and a model system for new strategies. Lancet Oncol 2003; 4: 429–437. (10.1016/S1470-2045(03)01141-0) / Lancet Oncol by AM Eggermont (2003)
  49. Herweijer H, Wolff JA . Progress and prospects: naked DNA gene transfer and therapy. Gene Therapy 2003; 10: 453–458. (10.1038/sj.gt.3301983) / Gene Therapy by H Herweijer (2003)
  50. Braun S . Duchenne muscular dystrophy gene therapy. Abstract Inv 26, ESGT 11th Annual Congress, November 14–17, 2003.
  51. Liang KW et al. Restoration of dystrophin expression in mdx mice by intravascular injection of naked DNA containing full-length dystrophin cDNA. Gene Ther 2004; 11: 901–908. (10.1038/sj.gt.3302239) / Gene Ther by KW Liang (2004)
  52. Taniyama Y et al. Development of safe and efficient novel nonviral gene transfer using ultrasound: enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle. Gene Therapy 2002; 9: 372–380. (10.1038/sj.gt.3301678) / Gene Therapy by Y Taniyama (2002)
  53. Taniyama Y et al. Local delivery of plasmid DNA into rat carotid artery using ultrasound. Circulation 2002; 105: 1233–1239. (10.1161/hc1002.105228) / Circulation by Y Taniyama (2002)
  54. Schratzberger P et al. Transcutaneous ultrasound augments naked DNA transfection of skeletal muscle. Mol Ther 2002; 6: 576–583. (10.1016/S1525-0016(02)90715-X) / Mol Ther by P Schratzberger (2002)
  55. Danialou G et al. Ultrasound increases plasmid-mediated gene transfer to dystrophic muscles without collateral damage. Mol Ther 2002; 6: 687–693. (10.1016/S1525-0016(02)90723-9) / Mol Ther by G Danialou (2002)
  56. Lu QL, Liang HD, Partridge T, Blomley MJ . Microbubble ultrasound improves the efficiency of gene transduction in skeletal muscle in vivo with reduced tissue damage. Gene Therapy 2003; 10: 396–405. (10.1038/sj.gt.3301913) / Gene Therapy by QL Lu (2003)
  57. Chen S et al. Optimization of ultrasound parameters for cardiac gene delivery of adenoviral or plasmid deoxyribonucleic acid by ultrasound-targeted microbubble destruction. J Am Coll Cardiol 2003; 42: 301–308. (10.1016/S0735-1097(03)00627-2) / J Am Coll Cardiol by S Chen (2003)
  58. Bekeredjian R et al. Ultrasound-targeted microbubble destruction can repeatedly direct highly specific plasmid expression to the heart. Circulation 2003; 108: 1022–1026. (10.1161/01.CIR.0000084535.35435.AE) / Circulation by R Bekeredjian (2003)
  59. Huber PE et al. Focused ultrasound (HIFU) induces localized enhancement of reporter gene expression in rabbit carotid artery. Gene Therapy 2003; 10: 1600–1607. (10.1038/sj.gt.3302045) / Gene Therapy by PE Huber (2003)
  60. Miller DL, Song J . Tumor growth reduction and DNA transfer by cavitation-enhanced high-intensity focused ultrasound in vivo. Ultrasound Med Biol 2003; 29: 887–893. (10.1016/S0301-5629(03)00031-0) / Ultrasound Med Biol by DL Miller (2003)
  61. Li T, Tachibana K, Kuroki M . Gene transfer with echo-enhanced contrast agents: comparison between Albunex, Optison, and Levovist in mice – initial results. Radiology 2003; 229: 423–428. (10.1148/radiol.2292020500) / Radiology by T Li (2003)
  62. Pislaru SV et al. Optimization of ultrasound-mediated gene transfer: comparison of contrast agents and ultrasound modalities. Eur Heart J 2003; 24: 1690–1698. (10.1016/S0195-668X(03)00469-X) / Eur Heart J by SV Pislaru (2003)
  63. Yamashita Y et al. In vivo gene transfer into muscle via electro-sonoporation. Hum Gene Ther 2002; 13: 2079–2084. (10.1089/10430340260395929) / Hum Gene Ther by Y Yamashita (2002)
  64. Zeira E et al. Femtosecond infrared laser – an efficient and safe in vivo gene delivery system for prolonged expression. Mol Ther 2003; 8: 342–350. (10.1016/S1525-0016(03)00184-9) / Mol Ther by E Zeira (2003)
  65. Durieux AC, Bonnefoy R, Manissolle C, Freyssenet D . High-efficiency gene electrotransfer into skeletal muscle: description and physiological applicability of a new pulse generator. Biochem Biophys Res Commun 2002; 296: 443–450. (10.1016/S0006-291X(02)00901-4) / Biochem Biophys Res Commun by AC Durieux (2002)
  66. Scherer F et al. Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo. Gene Therapy 2002; 9: 102–109. (10.1038/sj.gt.3301624) / Gene Therapy by F Scherer (2002)
  67. Chuang YC et al. Gene therapy for bladder pain with gene gun particle encoding pro-opiomelanocortin cDNA. J Urol 2003; 170: 2044–2048. (10.1097/01.ju.0000092945.76827.47) / J Urol by YC Chuang (2003)
  68. Kitagawa T et al. Advantages and limitations of particle-mediated transfection (gene gun) in cancer immuno-gene therapy using IL-10, IL-12 or B7-1 in murine tumor models. J Gene Med 2003; 5: 958–965. (10.1002/jgm.441) / J Gene Med by T Kitagawa (2003)
  69. Matsuno Y et al. Nonviral gene gun mediated transfer into the beating heart. ASAIO J 2003; 49: 641–644. (10.1097/01.MAT.0000093746.63497.AE) / ASAIO J by Y Matsuno (2003)
  70. Yoshizawa J et al. Successful in utero gene transfer using a gene gun in midgestational mouse fetuses. J Pediatr Surg 2004; 39: 81–84. (10.1016/j.jpedsurg.2003.09.001) / J Pediatr Surg by J Yoshizawa (2004)
  71. Martiniuk F et al. Helios gene gun particle delivery for therapy of acid maltase deficiency. DNA Cell Biol 2002; 21: 717–725. (10.1089/104454902760599690) / DNA Cell Biol by F Martiniuk (2002)
  72. Dileo J, Miller Jr TE, Chesnoy S, Huang L . Gene transfer to subdermal tissues via a new gene gun design. Hum Gene Ther 2003; 14: 79–87. (10.1089/10430340360464732) / Hum Gene Ther by J Dileo (2003)
  73. Trimble C et al. Comparison of the CD8+ T cell responses and antitumor effects generated by DNA vaccine administered through gene gun, biojector, and syringe. Vaccine 2003; 21: 4036–4042. (10.1016/S0264-410X(03)00275-5) / Vaccine by C Trimble (2003)
  74. Barfoed AM et al. Influence of routes and administration parameters on antibody response of pigs following DNA vaccination. Vaccine 2004; 22: 1395–1405. (10.1016/j.vaccine.2003.10.032) / Vaccine by AM Barfoed (2004)
  75. Lima KM et al. Efficacy of DNA-hsp65 vaccination for tuberculosis varies with method of DNA introduction in vivo. Vaccine 2003; 22: 49–56. (10.1016/S0264-410X(03)00543-7) / Vaccine by KM Lima (2003)
  76. Sasaki S et al. Adjuvant formulations and delivery systems for DNA vaccines. Methods 2003; 31: 243–254. (10.1016/S1046-2023(03)00140-3) / Methods by S Sasaki (2003)
  77. Zhu W, Thomas CE, Sparling PF . DNA immunization of mice with a plasmid encoding Neisseria gonorrhoeae PorB protein by intramuscular injection and epidermal particle bombardment. Vaccine 2004; 22: 660–669. (10.1016/j.vaccine.2003.08.036) / Vaccine by W Zhu (2004)
  78. Liu MA . DNA vaccines: a review. J Intern Med 2003; 253: 402–410. (10.1046/j.1365-2796.2003.01140.x) / J Intern Med by MA Liu (2003)
  79. Paster W et al. In vivo plasmid DNA electroporation generates exceptionally high levels of epitope-specific CD8+ T-cell responses. Gene Therapy 2003; 10: 717–724. (10.1038/sj.gt.3301942) / Gene Therapy by W Paster (2003)
  80. Babiuk S et al. Electroporation improves the efficacy of DNA vaccines in large animals. Vaccine 2002; 20: 3399–3408. (10.1016/S0264-410X(02)00269-4) / Vaccine by S Babiuk (2002)
  81. Arruda VR et al. Sustained correction of hemophilia B phenotype following intravascular delivery of AAV vector to skeletal muscle. Mol Ther 2002; 5: S157. / Mol Ther by VR Arruda (2002)
  82. Emani SM et al. Catheter-based intracoronary myocardial adenoviral gene delivery: importance of intraluminal seal and infusion flow rate. Mol Ther 2003; 8: 306–313. (10.1016/S1525-0016(03)00149-7) / Mol Ther by SM Emani (2003)
  83. Ding Z et al. A minimally invasive approach for efficient gene delivery to rodent hearts. Gene Therapy 2004; 11: 260–265. (10.1038/sj.gt.3302167) / Gene Therapy by Z Ding (2004)
  84. Chen S et al. Optimization of ultrasound parameters for cardiac gene delivery of adenoviral or plasmid deoxyribonucleic acid by ultrasound-targeted microbubble destruction. J Am Coll Cardiol 2003; 42: 301–308. (10.1016/S0735-1097(03)00627-2) / J Am Coll Cardiol by S Chen (2003)
Dates
Type When
Created 21 years ago (Aug. 5, 2004, 5:19 a.m.)
Deposited 2 years, 3 months ago (May 23, 2023, 1:39 p.m.)
Indexed 2 days, 1 hour ago (Aug. 24, 2025, 7 p.m.)
Issued 21 years ago (Aug. 5, 2004)
Published 21 years ago (Aug. 5, 2004)
Published Online 21 years ago (Aug. 5, 2004)
Published Print 20 years, 11 months ago (Sept. 1, 2004)
Funders 0

None

@article{Wells_2004, title={Gene Therapy Progress and Prospects: Electroporation and other physical methods}, volume={11}, ISSN={1476-5462}, url={http://dx.doi.org/10.1038/sj.gt.3302337}, DOI={10.1038/sj.gt.3302337}, number={18}, journal={Gene Therapy}, publisher={Springer Science and Business Media LLC}, author={Wells, D J}, year={2004}, month=aug, pages={1363–1369} }